Oscar Health (OSCR) Current Deferred Revenue (2020 - 2026)

Oscar Health has reported Current Deferred Revenue for 7 years, with the latest figure at $172.0 million in Q1 2026.

• For the quarter ending Q1 2026, Current Deferred Revenue rose 142.61% year-over-year to $172.0 million; the trailing twelve-month figure through Mar 2026 stood at $172.0 million (up 142.61% YoY), and the FY2025 full-year result was $166.2 million, up 123.42% from the prior year.
• Current Deferred Revenue for Q1 2026 stood at $172.0 million, up from $166.2 million in the prior quarter.
• The five-year high for Current Deferred Revenue was $172.0 million in Q1 2026, with the low at $60.0 million in Q2 2024.
• Historically, Current Deferred Revenue has averaged $82.8 million across 5 years, with a median of $73.1 million in 2023.
• Annual changes were most pronounced in 2024 — Current Deferred Revenue dropped 17.93% — and 2026, when it jumped 142.61%.
• Oscar Health's Current Deferred Revenue stood at $79.0 million in 2022, then slipped by 16.56% to $65.9 million in 2023, then climbed by 12.85% to $74.4 million in 2024, then surged by 123.42% to $166.2 million in 2025, then rose by 3.49% to $172.0 million in 2026.
• The last three Current Deferred Revenue figures came in at $172.0 million (Q1 2026), $166.2 million (Q4 2025), and $77.1 million (Q3 2025), per Business Quant data.